KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 -3.32%
Dec 28, 2025 24.10%
Sep 28, 2025 7.71%
Jun 29, 2025 8.84%
Mar 30, 2025 13.67%
Dec 31, 2023 -15.18%
Oct 1, 2023 40.73%
Jul 2, 2023 -15.54%
Apr 2, 2023 -37.31%
Jan 1, 2023 15.18%
Oct 2, 2022 -47.65%
Jul 3, 2022 -32.11%
Apr 3, 2022 -33.43%
Oct 3, 2021 -3.01%
Jul 4, 2021 9.45%
Apr 4, 2021 6.81%
Jan 3, 2021 -14.29%
Sep 27, 2020 1.14%
Jun 28, 2020 -4.29%
Mar 29, 2020 6.05%
Dec 29, 2019 9.73%
Sep 29, 2019 -18.07%
Jun 30, 2019 5.32%
Mar 31, 2019 -4.53%
Dec 30, 2018 -2.87%
Sep 30, 2018 5.70%
Jul 1, 2018 0.62%
Apr 1, 2018 4.54%
Dec 31, 2017 -43.91%
Oct 1, 2017 7.44%
Jul 2, 2017 22.14%
Apr 2, 2017 2.49%
Jan 1, 2017 35.11%
Oct 2, 2016 5.94%
Jul 3, 2016 7.56%
Apr 3, 2016 5.10%
Jan 3, 2016 11.02%
Sep 27, 2015 -0.35%
Jun 28, 2015 5.54%
Mar 29, 2015 -0.93%
Dec 28, 2014 9.30%
Sep 28, 2014 7.26%
Jun 29, 2014 6.16%
Mar 30, 2014 6.15%